AU1067300A - Pharmaceutical conjugates of glycoproteins and insoluble carriers - Google Patents

Pharmaceutical conjugates of glycoproteins and insoluble carriers

Info

Publication number
AU1067300A
AU1067300A AU10673/00A AU1067300A AU1067300A AU 1067300 A AU1067300 A AU 1067300A AU 10673/00 A AU10673/00 A AU 10673/00A AU 1067300 A AU1067300 A AU 1067300A AU 1067300 A AU1067300 A AU 1067300A
Authority
AU
Australia
Prior art keywords
glycoproteins
insoluble carriers
pharmaceutical conjugates
conjugates
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10673/00A
Inventor
Nicola Jane Church
Roy Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Healthcare UK Ltd
Original Assignee
Quadrant Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Healthcare UK Ltd filed Critical Quadrant Healthcare UK Ltd
Publication of AU1067300A publication Critical patent/AU1067300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10673/00A 1998-11-16 1999-11-15 Pharmaceutical conjugates of glycoproteins and insoluble carriers Abandoned AU1067300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9825105.1A GB9825105D0 (en) 1998-11-16 1998-11-16 Pharamaceutical conjugates
GB9825105 1998-11-16
PCT/GB1999/003803 WO2000029028A1 (en) 1998-11-16 1999-11-15 Pharmaceutical conjugates of glycoproteins and insoluble carriers

Publications (1)

Publication Number Publication Date
AU1067300A true AU1067300A (en) 2000-06-05

Family

ID=10842537

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10673/00A Abandoned AU1067300A (en) 1998-11-16 1999-11-15 Pharmaceutical conjugates of glycoproteins and insoluble carriers

Country Status (3)

Country Link
AU (1) AU1067300A (en)
GB (1) GB9825105D0 (en)
WO (1) WO2000029028A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2298354B1 (en) * 2001-10-10 2014-03-19 ratiopharm GmbH Remodelling and glycoconjugation of interferon-beta

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308617A (en) * 1988-08-10 1994-05-03 Halzyme Ltd. Protein heparin conjugates
ATE234080T1 (en) * 1994-12-16 2003-03-15 Elan Drug Delivery Ltd CROSS-LINKED MICROPARTICLES AND THEIR USE AS MEDICINAL CARRIERS
WO1998017319A2 (en) * 1996-10-21 1998-04-30 Quadrant Healthcare (Uk) Limited Platelet substitutes and conjugation methods suitable for their preparation
GB9724143D0 (en) * 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate

Also Published As

Publication number Publication date
WO2000029028A1 (en) 2000-05-25
GB9825105D0 (en) 1999-01-13

Similar Documents

Publication Publication Date Title
AU8230598A (en) Conjugate of polyethylene glycol and chitosan
AU5440901A (en) Cosmetic and/or pharmaceutical preparations
HUP0200444A2 (en) Polymer conjugates of interferon betha-1a and uses
AU9646198A (en) Isoquinoline derivative and drug
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
HUP0105411A3 (en) Palladium-substituted bacteriochlorophyll derivatives and use thereof
AU2543399A (en) Anticonvulsant drugs and pharmaceutical compositions thereof
AU1686600A (en) Chlorophyll-rich and salt-resistant chlorella
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
AUPQ342599A0 (en) Conjugates and uses thereof
AU2438400A (en) Cosmetic and/or pharmaceutical preparations
AU4293800A (en) Cosmetic and/or pharmaceutical preparations
AU7449198A (en) Phthalimide derivatives and pharmaceutical containing said derivatives
AU6179600A (en) Peptides and pharmaceutical compositions comprising same
AU1800100A (en) Medicinal preparations
AU1821300A (en) Peptides having anti-cancer and anti-inflammatory activity
AU1067300A (en) Pharmaceutical conjugates of glycoproteins and insoluble carriers
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs
AU2136401A (en) P450rai-2 and related proteins
HUP0001524A3 (en) Covalent phospholipid-phosphono-carboxylic acid conjugates and pharmaceutical compositions thereof
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
AU7651000A (en) Pharmaceutical and/or cosmetical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase